Investors

Medivir brings the Q1 webcast forward to 10 a.m. on April 30

Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI

FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease